CDC Warns of Person-to-Person Transmission of Resistant Fungus
CDC Warns of Person-to-Person Transmission of Resistant Fungus
In a first, patients who hadn’t been treated with antifungals were found to carry Candida auris impervious to all three available classes of the drugs.
CDC Warns of Person-to-Person Transmission of Resistant Fungus
CDC Warns of Person-to-Person Transmission of Resistant Fungus

In a first, patients who hadn’t been treated with antifungals were found to carry Candida auris impervious to all three available classes of the drugs.

In a first, patients who hadn’t been treated with antifungals were found to carry Candida auris impervious to all three available classes of the drugs.

drug resistance
Cross-Resistance: One Cancer Therapy Can Undermine the Next
Cross-Resistance: One Cancer Therapy Can Undermine the Next
Sophie Fessl | Jul 16, 2021
Targeted cancer therapy may jeopardize the effectiveness of subsequent immunotherapy by reducing dendritic cell numbers and activation, according to study of mice and patient samples.
A Connected Community: The Rise of Microbiome Research
A Connected Community: The Rise of Microbiome Research
The Scientist Creative Services Team | Apr 30, 2021
Explore how microbes shape health, disease, and the world beyond
Checking Checkpoints for Treating Cancer
Checking Checkpoints for Treating Cancer
The Scientist Creative Services Team | Mar 31, 2021
Researchers devise strategies to improve checkpoint inhibitor therapy and predict patient response.
Performing Metabolomic and Functional Proteomic Analyses on a Heterogenous Cancer Cell Population
Performing Metabolomic and Functional Proteomic Analyses on a Heterogenous Cancer Cell Population
The Scientist Creative Services Team in Collaboration with IsoPlexis | Mar 1, 2021
A tumor metabolome panel identifies altered cell states that lead to drug tolerance.
Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology
Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology
The Scientist Creative Services Team | Jan 20, 2021
Discover how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and devise new treatment strategies.
The Scientist's LabTalk - Episode 3
The Scientist's LabTalk - Episode 3
The Scientist Creative Services Team | Nov 13, 2020
Halting the Tuberculosis Epidemic with Research and Diagnostics: A Conversation with David Alland
Virus Hunters: Searching for Therapeutic Phages in a Drug Resistant World
Virus Hunters: Searching for Therapeutic Phages in a Drug Resistant World
The Scientist Creative Services Team | Sep 21, 2020
Researchers Jason Gill and Paul Turner will discuss their work on bacteriophage therapy to treat drug resistant bacterial infections.
A Multi-omics Approach to Overcome Solid Tumor Drug Resistance
A Multi-omics Approach to Overcome Solid Tumor Drug Resistance
The Scientist Creative Services Team | Aug 4, 2020
Download this research summary to learn about how single-cell proteomics and metabolomics methods unlock drug resistance mechanisms!
Infographic: Researchers Take Aim at Cancer Evolution
Infographic: Researchers Take Aim at Cancer Evolution
Catherine Offord | Apr 1, 2020
Strategies to trick, manipulate, and direct the evolution of tumors
Cancer Researchers Use Evolution to Target Drug Resistance
Cancer Researchers Use Evolution to Target Drug Resistance
Catherine Offord | Apr 1, 2020
New therapeutic approaches in oncology aim to manipulate or block cancer’s adaptation to treatment.
Cancer Cells Increase DNA Mutations to Evade Treatment
Cancer Cells Increase DNA Mutations to Evade Treatment
Abby Olena | Nov 7, 2019
Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.
First New Tuberculosis Drug Approved in 50 Years
First New Tuberculosis Drug Approved in 50 Years
Jef Akst | Aug 15, 2019
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.
FDA Suspends Clinical Trials Involving Fecal Transplants
FDA Suspends Clinical Trials Involving Fecal Transplants
Chia-Yi Hou | Jun 14, 2019
The agency issued a safety warning after two patients contracted antibiotic-resistant infections and one of the patients died.
Q&amp;A: What to Know About the Drug-Resistant Fungus, <em>Candida auris</em>
Q&A: What to Know About the Drug-Resistant Fungus, Candida auris
Emma Yasinski | Apr 18, 2019
Fungal researcher Christina Cuomo discusses the spread of infections plaguing hospitals across the world.
Infographic: Fighting Malaria Drug Resistance
Infographic: Fighting Malaria Drug Resistance
Natalie Slivinski | Mar 1, 2019
The parasite that causes malaria has evolved to evade many of the drugs that researchers have developed to fight the tropical disease.
Are We Headed for a New Era of Malaria Drug Resistance?
Are We Headed for a New Era of Malaria Drug Resistance?
Natalie Slivinski | Mar 1, 2019
Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.
Image of the Day: Tumor Organoids
Image of the Day: Tumor Organoids
The Scientist Staff, The Scientist Staff | Apr 11, 2018
Miniature versions of bladder cancers could help physicians identify personalized treatment options for patients.
Mutant RAS Proteins Team Up for Oncogenicity
Mutant RAS Proteins Team Up for Oncogenicity
Jim Daley | Apr 1, 2018
Mice with cancer whose KRAS proteins couldn’t link together had much better survival outcomes than those whose oncogenic mutant paired with wild-type KRAS.
New Class of Drugs Kills MRSA in Mice
New Class of Drugs Kills MRSA in Mice
Jim Daley | Mar 28, 2018
Researchers find two new antibiotics that offer promise in the fight against drug-resistant bacteria.